Kangji Medical Holdings Limited

HKEX:9997.HK

6.04 (HKD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22018 Q12017 Q42017 Q22017 Q12016 Q4
Revenue 458.413522.434403.589454.046332.321372.139318.124298.903212.587287.408216.059125.86788.41888.41888.41861.87761.87761.877
Cost of Revenue 95.29102.9981.83484.51166.60970.4456.89745.06734.95344.25236.0420.07316.09316.09316.09311.9511.9511.95
Gross Profit 363.123419.444321.755369.535265.712301.699261.227253.836177.634243.156180.019105.79472.32472.32472.32449.92649.92649.926
Gross Profit Ratio 0.7920.8030.7970.8140.80.8110.8210.8490.8360.8460.8330.8410.8180.8180.8180.8070.8070.807
Reseach & Development Expenses 43.35467.47860.07639.73926.2819.92716.07413.14412.0769.218.1674.3443.7153.7153.7152.6192.6192.619
General & Administrative Expenses 50.85454.85345.41638.27132.99836.33225.72823.8221.86812.04813.5311.9063.1473.1473.1472.0182.0182.018
Selling & Marketing Expenses 39.06237.28932.55329.47923.89325.50721.00825.68723.20724.16717.18810.3395.1275.1275.1272.9572.9572.957
SG&A 89.07491.55979.61666.05857.52962.45346.73649.50745.07536.28130.71912.2458.2748.2748.2744.9754.9754.975
Other Expenses 00000000000-14.86-10.572-10.572-10.572-6.497-6.497-6.497
Operating Expenses 132.428159.03791.93243.49896.73331.46248.35668.24170.25614.11834.5591.7291.4161.4161.4161.0971.0971.097
Operating Income 230.695260.407182.063263.738181.903219.319198.417191.185120.483197.665141.13367.72646.01746.01746.01735.3535.3535.35
Operating Income Ratio 0.5030.4980.4510.5810.5470.5890.6240.640.5670.6880.6530.5380.520.520.520.5710.5710.571
Total Other Income Expenses Net 97.03857.08289.219104.61212.89180.82935.9324.975-6.56840.68511.71130.07319.27319.27319.2735.1935.1935.193
Income Before Tax 327.733317.489271.282368.35194.794300.148234.349196.16113.915238.35152.84497.79965.2965.2965.2940.54340.54340.543
Income Before Tax Ratio 0.7150.6080.6720.8110.5860.8070.7370.6560.5360.8290.7070.7770.7380.7380.7380.6550.6550.655
Income Tax Expense 52.04794.49141.98560.67341.29742.71734.99126.60624.31942.26822.19116.1159.3429.3429.3425.9245.9245.924
Net Income 285.847248.56255.461321.022157.713257.431199.358169.55480.742122.82683.61881.68455.94855.94855.94834.61934.61934.619
Net Income Ratio 0.6240.4760.6330.7070.4750.6920.6270.5670.380.4270.3870.6490.6330.6330.6330.5590.5590.559
EPS 0.240.210.220.270.130.210.160.140.120.120.0810.0650.0450.0450.0450.0280.0280.028
EPS Diluted 0.240.210.220.270.130.210.160.140.120.120.0810.0650.0450.0450.0450.0280.0280.028
EBITDA 240.7271.734192.847271.732188.589224.446202.805195.087124.055201.095144.10169.43747.58347.58347.58336.96936.96936.969
EBITDA Ratio 0.5250.520.4780.5980.5670.6030.6380.6530.5840.70.6670.5520.5380.5380.5380.5970.5970.597